🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The Fake News Media, just like Election time 2016, is bringing up my Taxes & all sorts of other nonsense with illegally obtained information & only bad intent. I paid many millions of dollars in taxes but was entitled, like everyone else, to depreciation & tax credits.....

4am in ED: ‘Let’s just admit and ask for a 12 hour troponin and then request an echo for some time after I’ve left the trust’ academic.oup.com/eurheartj/eurh…

Mechanistic study of the effect of Endothelin SNPs in microvascular angina: sciencedirect.com/science/articl…. Grateful to Royal Papworth Hospital Research Dept. Royal Papworth Hospital NHS FT 💙, all colleagues and supervisors: Davenport_Lab Stephen Hoole Jo Oliveira 🌈🇵🇹🇬🇧💜💖💛 (she/her) Colin Berry Andrew Morrow Jonathan Weir-McCall Emma Davenport

Dr George Abraham, who's completing his MD at Catz, & our Fellow Prof Anthony Davenport (1995) are part of a team from the Cambridge University, Cambridge University Hospitals NHS, Royal Papworth Hospital NHS FT 💙 & AstraZeneca who discovered a new pathway for treating COVID-19 infections: caths.cam.ac.uk/pathway-COVID19 Davenport_Lab

ET: the extra therapeutic target. Our latest publication: doi.org/10.1016/j.yjmc… demonstrates a rationale for testing a new class of drugs for severe progressive Covid-19. Royal Papworth Hospital Research Dept.

Very pleased to share our latest paper: doi.org/10.1155/2022/9… exploring the key role of Endothelin-1 in post-PCI coronary microvascular dysfunction #cmd. With thanks to Royal Papworth Hospital Research Dept., supervisors: Davenport_Lab Stephen Hoole, all co-authors and patients.

Back to the future: check out our Cell preview paper discussing the ET pathway in resistant hypertension Davenport_Lab Royal Papworth Hospital Research Dept.

Our latest review of approved & investigational drugs including in combination with SGLT2 inhibitors now in Nature Cardiovascular Research:Current and future strategies for targeting the endothelin pathway in cardiovascular disease nature.com/articles/s4416… rdcu.be/dp7Q8

Differences in quantitative myocardial perfusion mapping by CMR at 1.5... sciencedirect.com/science/articl…

#SimPub #CircESC2024 In an RCT of participants with #microvascular angina, treatment with #zibotentan was not associated with difference in exercise capacity compared to placebo Rasha Al-Lamee Andrew Morrow George Abraham Colin Berry ahajournals.org/doi/10.1161/CI…